Company intelligence / Profile preview

NeuroDetect

Palo Alto, California, United Statesneurodetect.com ↗

Ownership: Private
Employees: ~3
Development stage: Preclinical

Overview

NeuroDetect is developing FDA-compliant software that creates precision-guided biomarker profiles for patients with neurological disorders. No specific clinical results are mentioned in the search results.

Therapeutic areas: Neurology
Modalities: Software platform with machine learning algorithms
Industry: Digital Health Medical Devices

Partnerships

West Coast Consortium for Technology & Innovation in Pediatrics (CTIP)

Beyond the preview

Go deeper on NeuroDetect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroDetect.

Explore the full profile